Remdesivir explained – what makes this drug work against viruses?

Simple item page
dc.contributor.authorSeley-Radtke, Katherine
dc.date.accessioned2025-07-30T19:22:53Z
dc.date.issued2020-05-06
dc.description.abstractGilead’s drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?
dc.description.sponsorshipDr. Katherine Seley-Radtke has previously consulted for Gilead Sciences and owns Gilead Sciences stock. She currently receives funding from the National Institutes of Health (NIH), the National Institute of General Medicine (NIGMS), the National Institute of Allergies and Infectious Diseases (NIAID).
dc.description.urihttp://theconversation.com/remdesivir-explained-what-makes-this-drug-work-against-viruses-137751
dc.format.extent4 pages
dc.genrearticles
dc.identifierdoi:10.13016/m2tcjx-jgnr
dc.identifier.citationSeley-Radtke, Katherine. “Remdesivir Explained – What Makes This Drug Work against Viruses?” The Conversation, May 6, 2020. http://theconversation.com/remdesivir-explained-what-makes-this-drug-work-against-viruses-137751.
dc.identifier.urihttp://hdl.handle.net/11603/39615
dc.language.isoen_US
dc.publisherThe Conversation
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsAttribution-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nd/4.0/
dc.titleRemdesivir explained – what makes this drug work against viruses?
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Remdesivirexplainedwhatmakesthisdrugworkagainstviruses_.pdf
Size:
622.7 KB
Format:
Adobe Portable Document Format
Download

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department